SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the crypto community discusses potential catalysts for a price surge, including comparisons to Bitcoin's movements and speculation about an upcoming alt season. Community members are debating Litecoin's utility and future growth potential, with some expressing frustration over its historical performance, while others point to its privacy features and upcoming ETFs. The conversations reflect a mix of hope for a breakout and concern about potential pump-and-dump schemes.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik ($RBRK) is trending amid discussions about its recent price action following earnings, with some investors viewing the dip as a buying opportunity and citing the company's growth potential in the cybersecurity and AI sectors. Community members are debating whether the stock is currently overvalued and some suggest potential acquisition by Crowdstrike ($CRWD). Several analysts have reiterated or upgraded their price targets, while others express frustration with the stock's performance.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as the community rallies around its real-world applications, from KENDU Energy to KENDU Unleashed skateboards, and the upcoming KENDU Games release on Steam. The community is actively discussing the best ways to "KENDU" everything, from real-life products to in-game integrations, reinforcing their belief in the long-term vision of the project. Holders are sharing bullish sentiments and celebrating the consistent building and marketing efforts of the project.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as the community discusses its potential and recent price action, with some speculating about a run to new highs. The focus is on ICP's technology and real-world utility, particularly with its integration of AI through Caffeine AI. Discussions also highlight the possibility of increased adoption and potential listings on major exchanges.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals is trending due to positive sentiment surrounding its RNAi platform and potential S&P 500 inclusion. Community discussions highlight the company's valuation, recent analyst target price increases, and actionable options trade alerts. Additionally, Alnylam's innovative approach in the biotech sector and potential as a retail squeeze candidate are sparking interest.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk ($NVO) is trending due to market speculation surrounding its bidding war with Pfizer for Metsera, with community chatter focusing on the potential impact of winning or losing the deal and what it signals for NVO's pipeline and strategic direction; some traders believe NVO may be overpaying for the asset. Investors are also closely watching upcoming FDA decisions on oral treatments and potential price adjustments amid broader discussions on access to weight-loss drugs.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

EXAS is trending amid discussions about its competitive positioning and potential catalysts, particularly related to upcoming earnings and product launches. Community members are weighing the impact of new products like Cancerguard against existing competition and evaluating the company's growth prospects. Recent analyst ratings and target price adjustments are also fueling the conversation around the stock's valuation.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors discuss the potential impact of recent acquisitions and upcoming contracts, particularly the Lunar Terrain Vehicle (LTV) project. Community members are weighing the implications of increased revenue and backlog against concerns of possible stock dilution. Bullish sentiment revolves around LUNR's strategic positioning in the growing space economy and its potential to secure lucrative government contracts.

AABG Token

AABB is trending as investors discuss the potential impact of rising gold and silver prices on the company's assets and future profitability. The community is also focused on upcoming catalysts, including the completion of share buybacks, the launch of the silver token, and updates on the new rGO production process. Some are anticipating positive news regarding a new concession and the details of recurring dividends.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy ($PRO) is trending amid volatile price action, sparking debates about its potential as a real-world asset (RWA) token; the community is actively discussing recent pumps and dumps, with some expressing frustration and others highlighting its long-term potential in the real estate space. Discussions range from potential AI integrations to broader market conditions and Propy's collaborations within the crypto ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 16,575 Shares of Stock

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Kenneth Bate sold 16,575 shares of Madrigal Pharmaceuticals stock in a transaction that occurred on Wednesday, November 5th...

FY2025 Earnings Estimate for MDGL Issued By B. Riley

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) - B. Riley decreased their FY2025 earnings per share (EPS) estimates for Madrigal Pharmaceuticals in a report released on Tuesday, November...

What is HC Wainwright's Estimate for MDGL FY2025 Earnings?

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) - Analysts at HC Wainwright lowered their FY2025 EPS estimates for Madrigal Pharmaceuticals in a report released on Wednesday, November 5th...

Cantor Fitzgerald Brokers Reduce Earnings Estimates for MDGL

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) - Equities research analysts at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for shares of Madrigal...

Equities Analysts Offer Predictions for MDGL FY2025 Earnings

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) - Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of Madrigal Pharmaceuticals in a report released on...

What is B. Riley's Estimate for MDGL Q4 Earnings?

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) - Research analysts at B. Riley issued their Q4 2026 earnings per share (EPS) estimates for shares of Madrigal Pharmaceuticals in a research...

Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $527.00 at Citizens Jmp

Citizens Jmp lifted their price target on Madrigal Pharmaceuticals from $485.00 to $527.00 and gave the company a "market outperform" rating in a report on Wednesday...

Madrigal Q3 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Up

MDGL's wider Q3 loss fails to deter investors, as soaring Rezdiffra sales drive revenues past estimates and lift the stock.

Madrigal (MDGL) Reports Q3 Loss, Tops Revenue Estimates

Madrigal (MDGL) delivered earnings and revenue surprises of -156.57% and +15.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate electroCore, Inc. (ECOR) to Report a Decline in Earnings: What to Look Out for

electroCore (ECOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.96	--	--	N/A
Q3 '25	-$2.29	-$5.08	-122.31%	MISSED
Q2 '25	-$3.55	-$1.90	46.54%	BEAT
Q1 '25	-$3.75	-$3.32	11.43%	BEAT
Q4 '24	-$3.84	-$2.71	29.34%	BEAT

MDGL
Madrigal Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest MDGL News

MDGLMadrigal Pharmaceuticals Inc